Clinical trial
Osteopontin Level and Promoter Polymorphism in Egyptian Metastatic Breast Cancer Patients
NCT04274504 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Osteopontin Level and Promoter Polymorphism in Egyptian Metastatic Breast Cancer Patients
- Lead sponsor
- Mansoura University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- November 30, 2019
- Enrollment
- 119 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
survival, prosthesis